Hans-Peter Hasler is a Swiss businessperson who founded Vicarius Pharma AG and who has been at the helm of 5 different companies. Mr. Hasler holds the position of Chairman at Medical Imaging Analysis Center, Chief Executive Officer & Director at Vicarius Pharma AG and Chairman at HBM Healthcare Investments AG.
He is also on the board of Minerva Neurosciences, Inc., Dr. Reddy's Laboratories SA and Shield Therapeutics Plc and Principal at Hph Management GmbH.
Hans-Peter Hasler previously occupied the position of Chief Operating Officer & Executive Vice President for Biogen, Inc. Chief Operating Officer at Biogen Idec, Inc. (North Carolina) and Executive Vice President-International at Biogen MA, Inc. (both are subsidiaries of Biogen, Inc.), Managing Director at Wyeth Pharma GmbH, Managing Director at Wyeth Pharmaceuticals AG, Chief Operating Officer at Elan Corp. Plc, Head-Global Strategic Marketing at Wyeth Pharmaceuticals LLC and Chief Marketing Officer at Wyeth Corp.
He received an undergraduate degree from Schweizerisches Institut für Betriebsökonomie AG.